What Vivos Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 2 |
| Sells | 0 | 0 |
| Total trades | 1 | 4 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 250,000 | 1,603,625 |
| Disposed | 0 | 0 |
| Net activity | +250,000 | +1,603,625 |
Common stock only — 1 reported trade in the last 12 months is in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Amman Bradford K. | Principal Accounting Officer | Jul 31 | Grant / award · A | +250,000 | $0.41 | +$103K | 250,080 |
| Huntsman Ronald Kirk | Chief Executive Officer | Jun 30 | Other Transaction · J | +85,910 | $0.58 | +$50K | 85,910 |
| Skaff Michael C | 10% owner | Mar 31 | Open-market buy · P | +308,848 | $1.34 | +$414K | 1,353,625 |
| Skaff Michael C | 10% owner | Mar 31 | Open-market buy · P | +1,044,777 | $1.34 | +$1.4M | 1,044,777 |
| Huntsman Ronald Kirk | Chief Executive Officer | Jun 20 | Open-market buy · P | +14,000 | $0.53 | +$7.42K | 86,521 |
| Huntsman Ronald Kirk | Chief Executive Officer | Jun 16 | Open-market buy · P | +5,000 | $0.53 | +$2.65K | 72,521 |
| Huntsman Ronald Kirk | Chief Executive Officer | Jun 16 | Open-market buy · P | +10,000 | $0.54 | +$5.4K | 67,521 |
| Huntsman Ronald Kirk | Chief Executive Officer | Jun 15 | Open-market buy · P | +21 | $0.50 | +$10.5 | 57,521 |
| Huntsman Ronald Kirk | Chief Executive Officer | Jun 14 | Open-market buy · P | +10,000 | $0.49 | +$4.9K | 57,500 |
| Huntsman Ronald Kirk | Chief Executive Officer | Dec 23 | Open-market buy · P | +20,000 | $0.50 | +$10K | 47,500 |
| Huntsman Ronald Kirk | Chief Executive Officer | Jun 01 | Open-market buy · P | +4,000 | $1.83 | +$7.32K | 27,500 |
| Huntsman Ronald Kirk | Chief Executive Officer | May 31 | Open-market buy · P | +8,000 | $2.03 | +$16.2K | 23,500 |
| Huntsman Ronald Kirk | Chief Executive Officer | Sep 21 | Open-market buy · P | +5,000 | $4.31 | +$21.6K | 15,500 |
| Huntsman Ronald Kirk | Chief Executive Officer | Aug 17 | Open-market buy · P | +5,000 | $3.00 | +$15K | 10,500 |
| Amman Bradford K. | Chief Financial Officer | May 25 | Open-market buy · P | +1,000 | $5.29 | +$5.29K | 2,000 |
| Huntsman Ronald Kirk | Chief Executive Officer | May 25 | Open-market buy · P | +4,000 | $5.38 | +$21.5K | 5,500 |
| Amman Bradford K. | Chief Financial Officer | Dec 24 | Open-market buy · P | +1,000 | $7.38 | +$7.38K | 1,000 |
| Huntsman Ronald Kirk | Chief Executive Officer | Dec 23 | Open-market buy · P | +1,000 | $7.27 | +$7.27K | 1,500 |
| Huntsman Ronald Kirk | Chief Executive Officer | Dec 11 | Open-market buy · P | +500 | $8.50 | +$4.25K | 500 |
Loading...
